PMID- 26121233 OWN - NLM STAT- MEDLINE DCOM- 20160510 LR - 20231213 IS - 1944-9917 (Electronic) IS - 0888-8809 (Print) IS - 0888-8809 (Linking) VI - 29 IP - 8 DP - 2015 Aug TI - Bone Morphogenic Protein 4 Mediates NOX1-Dependent eNOS Uncoupling, Endothelial Dysfunction, and COX2 Induction in Type 2 Diabetes Mellitus. PG - 1123-33 LID - 10.1210/ME.2014-1313 [doi] AB - We have recently shown that angiotensin II-mediated uncoupling of endothelial nitric oxide synthase (eNOS) contributes to endothelial dysfunction in streptozotocin-induced type 1 diabetes mellitus. However, it has remained unclear whether and how eNOS uncoupling occurs in type 2 diabetes mellitus (T2DM) and the consequences of such in regulating vascular function. Here we investigated a role of bone morphogenic protein (BMP)-4 in mediating eNOS uncoupling, endothelial dysfunction, and inflammation in db/db mice. Circulating levels of BMP4 were markedly elevated in db/db mice but not in mice with type 1 diabetes mellitus, in which angiotensin II levels were significantly increased. Infusion of BMP4 antagonist noggin into db/db mice (15 mug/kg/day, 4 weeks) abolished eNOS uncoupling activity while restoring tetrahydrobiopterin (H(4)B) bioavailability. The impaired endothelium-dependent vasorelaxation in db/db aortas was significantly improved by noggin infusion. Exposure of aortic endothelial cells to BMP4 (50 ng/mL, 24 hours) resulted in eNOS uncoupling, which was attenuated by H(4)B precursor sepiapterin or small interfering RNA silencing nicotinamide adenine dinucleotide phosphate oxidase isoform 1 (NOX1). Interestingly, BMP4-dependent NOX1 up-regulation was abrogated by sepiapterin, implicating a NOX1-uncoupled eNOS-NOX1 feed-forward loop. BMP4 induction of cyclooxygenase 2 (COX2) expression and vascular cell adhesion protein 1 was found in db/db mice. Consistently, COX2 was up-regulated by BMP4 in endothelial cells, which was attenuated by sepiapterin, implicating an upstream role of eNOS uncoupling in COX2-mediated inflammatory activation. Taken together, our data for the first time reveal a novel role of BMP4 in inducing NOX1-dependent eNOS uncoupling in T2DM, which may promote development of novel therapeutics restoring endothelial function in T2DM. FAU - Youn, Ji-Youn AU - Youn JY AD - Divisions of Molecular Medicine and Cardiology, Departments of Anesthesiology and Medicine, Cardivascular Research Laboratories, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California 90095. FAU - Zhou, Jun AU - Zhou J AD - Divisions of Molecular Medicine and Cardiology, Departments of Anesthesiology and Medicine, Cardivascular Research Laboratories, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California 90095. FAU - Cai, Hua AU - Cai H AD - Divisions of Molecular Medicine and Cardiology, Departments of Anesthesiology and Medicine, Cardivascular Research Laboratories, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California 90095. LA - eng GR - HL088975/HL/NHLBI NIH HHS/United States GR - R01 HL108701/HL/NHLBI NIH HHS/United States GR - HL108701/HL/NHLBI NIH HHS/United States GR - R01 HL119968/HL/NHLBI NIH HHS/United States GR - HL077440/HL/NHLBI NIH HHS/United States GR - R01 HL088975/HL/NHLBI NIH HHS/United States GR - R01 HL077440/HL/NHLBI NIH HHS/United States GR - HL119968/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20150629 PL - United States TA - Mol Endocrinol JT - Molecular endocrinology (Baltimore, Md.) JID - 8801431 RN - 0 (Blood Glucose) RN - 0 (Bmp4 protein, mouse) RN - 0 (Bone Morphogenetic Protein 4) RN - 0 (Carrier Proteins) RN - 0 (RNA, Small Interfering) RN - 11062-77-4 (Superoxides) RN - 11128-99-7 (Angiotensin II) RN - 148294-77-3 (noggin protein) RN - 0 (Biopterins) RN - 97C5T2UQ7J (Cholesterol) RN - EC 1.14.13.39 (Nitric Oxide Synthase Type III) RN - EC 1.14.13.39 (Nos3 protein, mouse) RN - EC 1.14.99.- (Ptgs2 protein, mouse) RN - EC 1.14.99.1 (Cyclooxygenase 2) RN - EC 1.6.- (NADH, NADPH Oxidoreductases) RN - EC 1.6.3.- (NADPH Oxidase 1) RN - EC 1.6.3.- (NOX1 protein, mouse) RN - EGX657432I (sapropterin) SB - IM MH - Angiotensin II/metabolism MH - Animals MH - Aorta/cytology/pathology MH - Biopterins/analogs & derivatives/chemistry MH - Blood Glucose/chemistry MH - Bone Morphogenetic Protein 4/*metabolism MH - Carrier Proteins/metabolism MH - Cattle MH - Cells, Cultured MH - Cholesterol/metabolism MH - Cyclooxygenase 2/*metabolism MH - Diabetes Mellitus, Type 2/*metabolism MH - Endothelial Cells/cytology/metabolism MH - Endothelium, Vascular/*metabolism MH - Inflammation/metabolism MH - Male MH - Mice MH - NADH, NADPH Oxidoreductases/*metabolism MH - NADPH Oxidase 1 MH - Nitric Oxide Synthase Type III/*metabolism MH - RNA, Small Interfering/metabolism MH - Superoxides/metabolism PMC - PMC4518001 EDAT- 2015/06/30 06:00 MHDA- 2016/05/11 06:00 PMCR- 2016/08/01 CRDT- 2015/06/30 06:00 PHST- 2015/06/30 06:00 [entrez] PHST- 2015/06/30 06:00 [pubmed] PHST- 2016/05/11 06:00 [medline] PHST- 2016/08/01 00:00 [pmc-release] AID - me-14-1313 [pii] AID - 10.1210/ME.2014-1313 [doi] PST - ppublish SO - Mol Endocrinol. 2015 Aug;29(8):1123-33. doi: 10.1210/ME.2014-1313. Epub 2015 Jun 29.